163 related articles for article (PubMed ID: 33352505)
21. Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study.
Ismail M; Aziz S; Noor S; Haider I; Shams F; Haq I; Khadim F; Khan Q; Khan F; Asif M
J Crit Care; 2017 Aug; 40():243-250. PubMed ID: 28458171
[TBL] [Abstract][Full Text] [Related]
22. Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study.
Klopotowska JE; Leopold JH; Bakker T; Yasrebi-de Kom I; Engelaer FM; de Jonge E; Haspels-Hogervorst EK; van den Bergh WM; Renes MH; Jong BT; Kieft H; Wieringa A; Hendriks S; Lau C; van Bree SHW; Lammers HJW; Wierenga PC; Bosman RJ; de Jong VM; Slijkhuis M; Franssen EJF; Vermeijden WJ; Masselink J; Purmer IM; Bosma LE; Hoeksema M; Wesselink E; de Lange DW; de Keizer NF; Dongelmans DA; Abu-Hanna A
Br J Clin Pharmacol; 2024 Jan; 90(1):164-175. PubMed ID: 37567767
[TBL] [Abstract][Full Text] [Related]
23. The Prevalence of Drug-Drug Interactions with Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in the Intensive Care Unit.
Johnston JP; Heavner MS; Liu M; Casal GLH; Akgün KM
J Pharm Pract; 2023 Apr; 36(2):322-328. PubMed ID: 34587846
[No Abstract] [Full Text] [Related]
24. Drug-Drug Interactions Among Hospitalized Children Receiving Chronic Antiepileptic Drug Therapy.
Lebowitz MB; Olson KL; Burns M; Harper MB; Bourgeois F
Hosp Pediatr; 2016 May; 6(5):282-9. PubMed ID: 27081190
[TBL] [Abstract][Full Text] [Related]
25. Drug Utilization and Potential Drug-Drug Interactions within an Intensive Care Unit at a University Tertiary Care Hospital in Egypt.
Obeid DF; Karara AH
Pharmacy (Basel); 2022 Aug; 10(4):. PubMed ID: 36005936
[TBL] [Abstract][Full Text] [Related]
26. Important drug classes associated with potential drug-drug interactions in critically ill patients: highlights for cardiothoracic intensivists.
Baniasadi S; Farzanegan B; Alehashem M
Ann Intensive Care; 2015 Dec; 5(1):44. PubMed ID: 26603290
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevancy and risks of potential drug-drug interactions in intensive therapy.
Rodrigues AT; Stahlschmidt R; Granja S; Falcão AL; Moriel P; Mazzola PG
Saudi Pharm J; 2015 Sep; 23(4):366-70. PubMed ID: 27134536
[TBL] [Abstract][Full Text] [Related]
28. Potential Drug-Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center.
Hassanzad M; Arenas-Lopez S; Baniasadi S
J Clin Pharmacol; 2018 Feb; 58(2):221-227. PubMed ID: 28834562
[TBL] [Abstract][Full Text] [Related]
29. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study.
Ismail M; Noor S; Harram U; Haq I; Haider I; Khadim F; Khan Q; Ali Z; Muhammad T; Asif M
BMC Health Serv Res; 2018 Oct; 18(1):762. PubMed ID: 30314487
[TBL] [Abstract][Full Text] [Related]
30. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
Noor S; Ismail M; Khan F
Front Pharmacol; 2019; 10():1032. PubMed ID: 31607905
[No Abstract] [Full Text] [Related]
31. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
[TBL] [Abstract][Full Text] [Related]
32. Clinically Significant Cytochrome P450-Mediated Drug-Drug Interactions in Children Admitted to Intensive Care Units.
Li T; Hu B; Ye L; Feng Z; Huang L; Guo C; Wu X; Tan W; Wang Y; Yang G; Guo C
Int J Clin Pract; 2022; 2022():2786914. PubMed ID: 36081809
[TBL] [Abstract][Full Text] [Related]
33. The impact of antimicrobial use on potential major drug-drug interactions in the pediatric Intensive Care Unit patients at University Hospital in Türkiye.
Albayrak A; Akkuzu E; Karahalil B
Minerva Pediatr (Torino); 2024 Jun; 76(3):388-394. PubMed ID: 33858128
[TBL] [Abstract][Full Text] [Related]
34. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins.
Egger SS; Rätz Bravo AE; Hess L; Schlienger RG; Krähenbühl S
Drugs Aging; 2007; 24(5):429-40. PubMed ID: 17503898
[TBL] [Abstract][Full Text] [Related]
35. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
36. Recognition and management of potential drug-drug interactions in patients on internal medicine wards.
Vonbach P; Dubied A; Beer JH; Krähenbühl S
Eur J Clin Pharmacol; 2007 Nov; 63(11):1075-83. PubMed ID: 17805522
[TBL] [Abstract][Full Text] [Related]
37. Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021.
Bačar Bole C; Nagode K; Pišlar M; Mrhar A; Grabnar I; Vovk T
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837485
[No Abstract] [Full Text] [Related]
38. Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
Noor S; Ismail M; Ali Z
BMC Pharmacol Toxicol; 2019 Jul; 20(1):45. PubMed ID: 31349877
[TBL] [Abstract][Full Text] [Related]
39. Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Noor S; Ismail M; Haider I; Khadim F
Ann Hepatol; 2018 Oct; 17(6):1001-1011. PubMed ID: 30600298
[TBL] [Abstract][Full Text] [Related]
40. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
Schneider KL; Kastenmüller K; Weckbecker K; Bleckwenn M; Böhme M; Stingl JC
Drugs Aging; 2018 Jun; 35(6):559-568. PubMed ID: 29737468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
